• Mon news: Novartis in $745M radiopharma pact. Novo launches Wegovy in China. COVID-era telehealth prescribing extended. Hims & Hers GLP-1 tracker. Promising Gilead liver disease trial. See more on our front page

Attention Ken & Roger

Anonymous

Guest
You do realize that Merck will soon be losing 100% of its HCV Sales Force (80% to Abbvie and the ones the were not good enough to BI; ie the other 20%)

I just wanted you to know that - because I wanted to give you "heads-up" before all the Analysts rip you a new one over it.

Be Well
 




























You do realize that Merck will soon be losing 100% of its HCV Sales Force (80% to Abbvie and the ones the were not good enough to BI; ie the other 20%)

I just wanted you to know that - because I wanted to give you "heads-up" before all the Analysts rip you a new one over it.

Be Well

Thank you for your candor and info. I am on my yacht off the shore right now catching up on CP posts. After my copter takes me home I will let you know why you should stay. Hold on "waiter, another mag of Dom please". Sorry for that, we came a bit close to another vessel. The stern reads "steady fast freddie". Kenny F.